Covid

Several new studies reveal that getting multiple COVID vaccine doses provides strong protection against lingering symptoms

The fight of a generation.

Information control has replaced infection control, and that does not bode well for the near- and medium-term future of the human species on planet Earth.

An international research team, including Jonathan C. Schisler, PhD, in the UNC School of Medicine, has found how SARS-CoV-2 causes widespread “energy outages” throughout major organs, and how these effects contribute to debilitating long COVID symptoms.

Researchers increasingly find that the effects of infection by SARS-CoV-2 extend to the cardiovascular system

Maternal Covid-19 vaccination offers infants immunity for up to six months, a new study finds.

archived 19 Oct 2023 01:28:31 UTC

Limited data and lack of head-to-head studies make comparisons tricky

Since the last BA.2.86 update, lab and epidemiological data have trickled in. Many of us took a big sigh of relief after seeing specific results over the weekend. Here is your update. Lab data Three labs have already tested BA.2.86 in a petri dish. (The speed of scientific discovery for SARS-CoV-2 still amazes me). They found three main things:

Questions about ProMED's future persist, as striking moderators face a new deadline.

We have a new COVID-19 variant—BA.2.86—turning heads even among the calm, cool, and collected scientists. This is what we know, what we don’t know, and what’s likely next. What is happening? SARS-CoV-2 continues to mutate. This is expected, as this is what viruses do to survive. There was ~20% possibility of another “Omicron-like event” in 2023. Since Omicron arrived on the scene in November 2021, we’ve only seen incremental changes, which have created a ladder-like pattern (see panel A below). This is a good thing—we

A quick summer update — COVID levels are starting trend back up again, and there’s a new variant to watch.

In 2005, web magazine Salon, with Rolling Stone as its partner, published Robert F. Kennedy’s article “Deadly Immunity,” about how thimerosal in childhood vaccines supposedly led …

Remember monkeypox? Well, it’s now known as “mpox.” And you may start seeing it pop up in the news again. We have learned a lot since the massive outbreak last summer, but still have a lot of unanswered questions. Here’s what you need to know, particularly going into Pride month.

Bacteria in the recalled drops are so drug-resistant, docs turn to phage therapy.

The booster confusion in emails I have received over the past week is palpable. Should I get a spring booster? This is how I’m thinking about it. Hopefully it helps. Level of urgency The level of urgency for a spring booster should be dependent on two things:

What was once outright denial has morphed into a subtler dismissal.

People aged 65 and older and those who are immunocompromised will be allowed to receive an additional dose of Covid-19 vaccine — a spring booster — if they wish, the FDA announced Tuesday.

The genetic data paints a picture of spillover in one zone of the market.

The body of evidence expands

We don't need an answer before acting.